7079 Stock Overview
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
WDB coco Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥4,635.00 |
52 Week High | JP¥6,580.00 |
52 Week Low | JP¥4,480.00 |
Beta | 0.17 |
1 Month Change | -5.41% |
3 Month Change | -0.22% |
1 Year Change | -5.12% |
3 Year Change | 12.23% |
5 Year Change | n/a |
Change since IPO | 31.12% |
Recent News & Updates
Recent updates
Shareholder Returns
7079 | JP Life Sciences | JP Market | |
---|---|---|---|
7D | -1.2% | 1.2% | 1.7% |
1Y | -5.1% | -29.0% | 37.6% |
Return vs Industry: 7079 exceeded the JP Life Sciences industry which returned -29% over the past year.
Return vs Market: 7079 underperformed the JP Market which returned 37.6% over the past year.
Price Volatility
7079 volatility | |
---|---|
7079 Average Weekly Movement | 2.2% |
Life Sciences Industry Average Movement | 6.2% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 7079 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7079's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 471 | n/a | https://www.wdbcoco.com |
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services.
WDB coco Co., Ltd. Fundamentals Summary
7079 fundamental statistics | |
---|---|
Market cap | JP¥11.15b |
Earnings (TTM) | JP¥772.00m |
Revenue (TTM) | JP¥4.39b |
14.4x
P/E Ratio2.5x
P/S RatioIs 7079 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7079 income statement (TTM) | |
---|---|
Revenue | JP¥4.39b |
Cost of Revenue | JP¥2.63b |
Gross Profit | JP¥1.75b |
Other Expenses | JP¥980.00m |
Earnings | JP¥772.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 321.01 |
Gross Margin | 39.95% |
Net Profit Margin | 17.61% |
Debt/Equity Ratio | 0% |
How did 7079 perform over the long term?
See historical performance and comparison